Related Experiment Videos
2-Fluoroestradiol. Separation of estrogenicity from carcinogenicity
Abstract:
Estrogenic and carcinogenic activity are shown to be separable properties. 2-Fluoroestradiol, a modified estrogen, did not induce renal clear-cell carcinoma in male Syrian hamsters despite its estrogenic potency, which is comparable to that of estradiol. 4-Fluoroestradiol, also a potent estrogen, did induce renal clear-cell carcinoma in this animal model, but more slowly than estradiol. 2,4-Dideuterioestradiol was found to be as estrogenic and also as carcinogenic as estradiol itself.
Insights
Estrogenic and carcinogenic activities can be separated. Modified estrogens showed varied effects on renal clear-cell carcinoma in hamsters, indicating distinct mechanisms for estrogenic and carcinogenic actions.
Area of Science:
- Endocrinology and toxicology
- Carcinogenesis research
- Steroid hormone action
Background:
- Estrogenic compounds can exhibit carcinogenic properties.
- Understanding the relationship between estrogenic activity and carcinogenicity is crucial for drug development and risk assessment.
- Modified estrogens offer a tool to dissect these biological activities.
Purpose of the Study:
- To investigate whether estrogenic and carcinogenic activities are separable properties.
- To evaluate the carcinogenic potential of modified estrogens in a relevant animal model.
- To elucidate the role of specific molecular modifications in determining estrogen-induced carcinogenesis.
Main Methods:
- Administration of modified estrogens (2-Fluoroestradiol, 4-Fluoroestradiol, 2,4-Dideuterioestradiol) and estradiol to male Syrian hamsters.
- Monitoring for the induction of renal clear-cell carcinoma.
- Assessing the estrogenic potency of the tested compounds.
Main Results:
- 2-Fluoroestradiol, despite potent estrogenicity, did not induce renal clear-cell carcinoma.
- 4-Fluoroestradiol induced renal clear-cell carcinoma, but at a slower rate than estradiol.
- 2,4-Dideuterioestradiol exhibited both estrogenic and carcinogenic activities comparable to estradiol.
Conclusions:
- Estrogenic and carcinogenic activities of estradiol derivatives are separable.
- Fluorination at the 2-position of estradiol may abolish carcinogenic potential while retaining estrogenicity.
- The position and type of modification on the estrogen molecule significantly influence its carcinogenic activity in this model.